{"id":454233,"date":"2021-03-09T16:33:18","date_gmt":"2021-03-09T21:33:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454233"},"modified":"2021-03-09T16:33:18","modified_gmt":"2021-03-09T21:33:18","slug":"viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/","title":{"rendered":"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOULDER, Colo., March  09, 2021  (GLOBE NEWSWIRE) &#8212; Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies, today announced that it will host a conference call and webcast on Thursday, March 25, 2021 at 4:30 p.m. ET to discuss a corporate update and results for the fourth quarter and full year 2020.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\">\n            <strong>Conference Call &amp; Webcast Details<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%\">Date:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%\">Thursday, March 25, 2021<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>4:30 pm Eastern Time<\/td>\n<\/tr>\n<tr>\n<td>Domestic:<\/td>\n<td>877-407-0789<\/td>\n<\/tr>\n<tr>\n<td>International:<\/td>\n<td>201-689-8562<\/td>\n<\/tr>\n<tr>\n<td>Conference ID:<\/td>\n<td>13717079<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"https:\/\/investors.viridiantherapeutics.com\/events\/default.aspx\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/investors.viridiantherapeutics.com\/events\/default.aspx<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>A live webcast of the conference call can be accessed in the Investors section of Viridian Therapeutics website at https:\/\/investors.viridiantherapeutics.com<\/p>\n<p>\n        <strong>About Viridian Therapeutics<\/strong>\n      <\/p>\n<p>Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies. Viridian\u2019s most advanced program, VRDN-001, is an anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED), a debilitating auto-immune disease that causes inflammation and fibrosis within the orbit of the eye which can cause double vision, pain, and potential blindness. Patients with severe disease often require multiple remedial surgeries to the orbit, eye muscles and eyelids Viridian is headquartered in Boulder, Colorado, with additional operations in Waltham, Massachusetts. Learn more about Viridian and our programs at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rPYnkKCcomBTZ2KAijXq0fWAdjsqUxEDXMCV1C4dZVHsmJPhmzRCvhD6j00QIZwV5Q4JF_uH031yKCc5Y2Q8aoLoWuHLkE8QvsyNCPJTHN6S-tN9fkVLBBOpgLd1JSel\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.viridiantherapeutics.com<\/a>.<\/p>\n<p>Follow us on Twitter @ViridianThera and on LinkedIn.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>Investors<br \/>Dan Ferry<br \/>LifeSci Advisors<br \/>617-430-7576<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R-o4--1H3qzBCo26tEat-5mXudDLjBzejcP0-JdvvTEf9wo_qoBycYjqwDIB5TYfKSdBrll8gg6lWLnOFim7B2AS2ViebImkIQ0GckaimuAYWJ6n6tcwp8o9xY_TfjR_\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">IR@viridiantherapeutics.com<\/a><\/p>\n<p>Media<br \/>Darby Pearson<br \/>Verge Scientific Communications<br \/>703-587-0831<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HFlACcJxAwjY2XHtmIxFaTJphK35VAL7CsQqTDqRFrW5IztgYntrAZJUk0c-SPgfmDg2KR3jL4bYaZx_sH0-SxIvjwJqWKT6BEJC6Gah7UMMNmmBKjaGsEc_Y7MIjGq1\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">PR@viridiantherapeutics.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/dc14b7e6-e795-450b-a5b6-3ba1e89c388b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOULDER, Colo., March 09, 2021 (GLOBE NEWSWIRE) &#8212; Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies, today announced that it will host a conference call and webcast on Thursday, March 25, 2021 at 4:30 p.m. ET to discuss a corporate update and results for the fourth quarter and full year 2020. Conference Call &amp; Webcast Details Date: Thursday, March 25, 2021 Time: 4:30 pm Eastern Time Domestic: 877-407-0789 International: 201-689-8562 Conference ID: 13717079 Webcast: https:\/\/investors.viridiantherapeutics.com\/events\/default.aspx A live webcast of the conference call can be accessed in the Investors section of Viridian Therapeutics website at https:\/\/investors.viridiantherapeutics.com About Viridian Therapeutics Viridian Therapeutics is a biotechnology company advancing new &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454233","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOULDER, Colo., March 09, 2021 (GLOBE NEWSWIRE) &#8212; Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies, today announced that it will host a conference call and webcast on Thursday, March 25, 2021 at 4:30 p.m. ET to discuss a corporate update and results for the fourth quarter and full year 2020. Conference Call &amp; Webcast Details Date: Thursday, March 25, 2021 Time: 4:30 pm Eastern Time Domestic: 877-407-0789 International: 201-689-8562 Conference ID: 13717079 Webcast: https:\/\/investors.viridiantherapeutics.com\/events\/default.aspx A live webcast of the conference call can be accessed in the Investors section of Viridian Therapeutics website at https:\/\/investors.viridiantherapeutics.com About Viridian Therapeutics Viridian Therapeutics is a biotechnology company advancing new &hellip; Continue reading &quot;Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-09T21:33:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update\",\"datePublished\":\"2021-03-09T21:33:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/\"},\"wordCount\":260,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/\",\"name\":\"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=\",\"datePublished\":\"2021-03-09T21:33:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/","og_locale":"en_US","og_type":"article","og_title":"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update - Market Newsdesk","og_description":"BOULDER, Colo., March 09, 2021 (GLOBE NEWSWIRE) &#8212; Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from serious diseases but underserved by today\u2019s therapies, today announced that it will host a conference call and webcast on Thursday, March 25, 2021 at 4:30 p.m. ET to discuss a corporate update and results for the fourth quarter and full year 2020. Conference Call &amp; Webcast Details Date: Thursday, March 25, 2021 Time: 4:30 pm Eastern Time Domestic: 877-407-0789 International: 201-689-8562 Conference ID: 13717079 Webcast: https:\/\/investors.viridiantherapeutics.com\/events\/default.aspx A live webcast of the conference call can be accessed in the Investors section of Viridian Therapeutics website at https:\/\/investors.viridiantherapeutics.com About Viridian Therapeutics Viridian Therapeutics is a biotechnology company advancing new &hellip; Continue reading \"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-09T21:33:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update","datePublished":"2021-03-09T21:33:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/"},"wordCount":260,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/","name":"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=","datePublished":"2021-03-09T21:33:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjU3OSM0MDU0MjgxIzIwMjc5NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/viridian-therapeutics-to-host-conference-call-discussing-fourth-quarter-and-full-year-2020-results-and-corporate-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454233"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454233\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}